OSIMPLANT Chooses Invibio’s Polymer for Cervical Disc Implant

OSIMPLANT has selected Invibio Biomaterial Solutions’ MOTIS polymer for its CE marked ARAMIS cervical disc prosthesis.

Advertisement

The MOTIS polymer was chosen for its mechanical strength, creep resistance and wear performance. Designed to minimize patient pain and combat spinal degenerative diseases such as spondylosis and herniated nucleus pulposus, ARAMIS relies on MOTIS’ performance properties to advance patient and surgeon benefits.

More Articles on Orthopedic Devices:

FDA Recalls GE’s Spinal Navigation System

Orchid Medical Acquires WIN’s Surgical Implant Business

Investors Sue Internal Fixation Systems Over Alleged Misinformation

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.